In-Vitro Transcription Templates Market: By Product Type (DNA templates, RNA Templates, Templates and Transcription Kits, Other Product Types), By Disease Type (Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases), By Application (Research, Diagnostics, Therapeutics, Vaccines and Others), By Research stage (Explanatory, Clinical),By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations (CROs)) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

In-Vitro Transcription Templates Market size was valued at USD 256.8 million in 2023 and is expected to grow at a 17.4% CAGR from 2024 to 2030. In-vitro transcription is a laboratory technique used to synthesize RNA molecules from a DNA template outside of living cells. In-vitro transcription templates are DNA sequences that contain all of the components required for transcription, such as a promoter recognized by RNA polymerase, the gene or sequence of interest, and a terminator. These templates can be obtained from plasmids, PCR products, or synthesized oligonucleotides and it provides a blueprint for RNA synthesis during in-vitro transcription. These templates find applications in molecular biology, including the study of gene function, production of RNA probes, etc.

The market for this is huge, as this is one of the centres of biotechnological research. Increase in the prevalence of chronic diseases and the need for new diagnostic and treatment strategies, increasing research activities, especially in molecular biology, genomics and transcriptomics, the growing biopharmaceutical sector, technological advancements and availability of research infrastructure and skilled labourers are the main factors driving the market. A noted point to mention, this technology was extensively used to find the mRNA-based vaccine for COVID-19, when most of the industries saw a downfall, this market was booming because of the ongoing research and its potential. Although all the driving factors are present, the high cost associated with high-purity enzymes, nucleotides, and specialized equipment and technological difficulties such as effective transcription templates and optimizing transcription reactions, faced while developing and using them are still major drawbacks for this market. However, investing heavily in biotechnology and life sciences research, taking this as an opportunity companies can enter into emerging markets. Also finding new applications are the templates can lead to future market growth, for example focusing on personalised medicine as patient-specific RNA sequence treatment.

In-Vitro Transcription Templates Market Key Developments:
  • In September 2023, GenScript Biotech Corporation enhanced its IVT mRNA synthesis offerings by introducing personalized circular RNA (circRNA) and lipid nanoparticles (LNPs). GenScript has introduced new contract-manufactured reagent services as a demonstration of their state-of-the-art reagents that facilitate progress in areas such as vaccine development, protein replacement therapies, and gene and cell therapy.
  • In September 2023, Merck became the first CT DMO to offer fully integrated services for mRNA development, manufacturing, commercialization, and product testing using Invitro Transcription template technology. This achievement was supported by the opening of two GMP- grade mRNA drug substance manufacturing sites in Darmstadt and Hamburg,
  • In January 2023, NEB recently launched their HiScribe T7 High Yield RNA Synthesis Kit. This kit is designed for high-yield in-vitro transcription of RNA, offering improved efficiency and yield compared to previous versions. It includes optimized reagents and protocols for robust RNA synthesis applications.

In Vitro Transcription Templates Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

17.4%

Largest Market

North-America

Fastest Growing Market

North-America
In-Vitro Transcription Templates Market Dynamics

The growing shift of the research towards RNA has been pivotal in the In Vitro Transcription Templates Market growth. Especially, the COVID-19 pandemic had a positive impact on the In Vitro Transcription Templates Market as the development of mRNA vaccines utilized the invitro transcription templates. The rise of adaptation of personalised medicine (produce custom RNA molecules that can regulate gene expression), gene therapies, focusing on high throughput and growing emphasis on regulatory and quality standards for in-vitro transcription templates are the main trends of the market. After all, the market is highly competitive, with several key players introducing new products with advancements and more benefits. Key market players are engaging in collaborations and strategic partnerships with academic institutions or other companies to foster innovation such as BioNTech and Pfizer collaborated during COVID-19 for the development of RNA vaccines. Apart from all this, companies go head-to-head over intellectual property in this product as it’s emerging many companies want to own patents.

In Vitro Transcription Templates Market Segmentation

By Product Type
  • DNA Templates
  • RNA Templates
  • Templates and Transcription kits
  • Other Product Types
By Disease Type
  • Cancer
  • Infectious Disease
  • Lifestyle Disease
  • Genetic Disease
  • Other Diseases
By Application
  • Research
  • Diagnostics
  • Therapeutics
  • Vaccines
  • Others
By Research Stage
  • Explanatory
  • Clinical
By End User
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

Frequently Asked Questions

The In Vitro Transcription Templates Market size was valued at USD 256.8 million in 2023 and is expected to grow at a 17.4 % CAGR from 2024 to 2030

Thermo Fisher Scientific, Inc. , Promega Corporation , Agilent Technologies, Inc. ,New England Biolabs , Takara Bio Inc., Inc. Cytiva (Danaher) are the prominent players offering In-vitro Transcription Templates are some of the key players in the In Vitro Transcription Templates Market.

Rise in prevalence of chronic diseases and need of new diagnostic and treatment strategies, increasing research activities especially in molecular biology, genomics and transcriptomics, growing biopharmaceutical sector, technological advancements and availability of research infrastructure and skilled labours are the main factors driving the market.

North America leads the in-vitro transcription templates market due to the presence of large biotechnology and pharmaceutical businesses, modern research infrastructure, and significant funding for life sciences research.

Key Features of the Reports

  • The in-vitro transcription templates market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1.Executive Summary
2.Global In-Vitro Transcription Templates Market Introduction 
2.1.Global In-Vitro Transcription Templates Market  - Taxonomy
2.2.Global In-Vitro Transcription Templates Market  - Definitions
2.2.1.Product Type
2.2.2.Disease Type
2.2.3. Application
2.2.4.Research Stage
2.2.5.End User
2.2.6.Region
3.Global In-Vitro Transcription Templates Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global In-Vitro Transcription Templates Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global In-Vitro Transcription Templates Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. DNA Templates
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. RNA Templates
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Templates and Transcription kits
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Other Product Types
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global In-Vitro Transcription Templates Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Cancer
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Infectious Disease
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Lifestyle Disease
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Genetic Disease
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Other Diseases
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global In-Vitro Transcription Templates Market  By  Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Research
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Therapeutics
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Vaccines
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global In-Vitro Transcription Templates Market  By Research Stage, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Explanatory
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Clinical
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9.Global In-Vitro Transcription Templates Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Biotechnology & Pharmaceutical Companies
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Academic & Research Institutes
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Contract Research Organizations (CROs)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
10.Global In-Vitro Transcription Templates Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. North America
10.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.1.3. Market Opportunity Analysis 
10.2. Europe
10.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.2.3. Market Opportunity Analysis 
10.3. Asia Pacific (APAC)
10.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.3.3. Market Opportunity Analysis 
10.4. Middle East and Africa (MEA)
10.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.4.3. Market Opportunity Analysis 
10.5. Latin America
10.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
10.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.5.3. Market Opportunity Analysis 
11.North America In-Vitro Transcription Templates Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.DNA Templates
11.1.2.RNA Templates
11.1.3.Templates and Transcription kits
11.1.4.Other Product Types
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cancer
11.2.2.Infectious Disease
11.2.3.Lifestyle Disease
11.2.4.Genetic Disease
11.2.5.Other Diseases
11.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Research
11.3.2.Diagnostics
11.3.3.Therapeutics
11.3.4.Vaccines
11.3.5.Others
11.4.  Research Stage Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Explanatory
11.4.2.Clinical
11.5.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Biotechnology & Pharmaceutical Companies
11.5.2.Academic & Research Institutes
11.5.3.Contract Research Organizations (CROs)
11.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.6.1.United States of America (USA)
11.6.2.Canada
12.Europe In-Vitro Transcription Templates Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.DNA Templates
12.1.2.RNA Templates
12.1.3.Templates and Transcription kits
12.1.4.Other Product Types
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cancer
12.2.2.Infectious Disease
12.2.3.Lifestyle Disease
12.2.4.Genetic Disease
12.2.5.Other Diseases
12.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Research
12.3.2.Diagnostics
12.3.3.Therapeutics
12.3.4.Vaccines
12.3.5.Others
12.4.  Research Stage Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Explanatory
12.4.2.Clinical
12.5. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.Biotechnology & Pharmaceutical Companies
12.5.2.Academic & Research Institutes
12.5.3.Contract Research Organizations (CROs)
12.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.6.1.Germany
12.6.2.France
12.6.3.Italy
12.6.4.United Kingdom (UK)
12.6.6.Spain
13.Asia Pacific (APAC) In-Vitro Transcription Templates Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.DNA Templates
13.1.2.RNA Templates
13.1.3.Templates and Transcription kits
13.1.4.Other Product Types
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cancer
13.2.2.Infectious Disease
13.2.3.Lifestyle Disease
13.2.4.Genetic Disease
13.2.5.Other Diseases
13.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Research
13.3.2.Diagnostics
13.3.3.Therapeutics
13.3.4.Vaccines
13.3.5.Others
13.4.  Research Stage Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Explanatory
13.4.2.Clinical
13.5. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.Biotechnology & Pharmaceutical Companies
13.5.2.Academic & Research Institutes
13.5.3.Contract Research Organizations (CROs)
13.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.6.1.China
13.6.2.India
13.6.3.Australia and New Zealand (ANZ)
13.6.4.Japan
13.6.6.Rest of APAC
14.Middle East and Africa (MEA) In-Vitro Transcription Templates Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.DNA Templates
14.1.2.RNA Templates
14.1.3.Templates and Transcription kits
14.1.4.Other Product Types
14.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Cancer
14.2.2.Infectious Disease
14.2.3.Lifestyle Disease
14.2.4.Genetic Disease
14.2.5.Other Diseases
14.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Research
14.3.2.Diagnostics
14.3.3.Therapeutics
14.3.4.Vaccines
14.3.5.Others
14.4.  Research Stage Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Explanatory
14.4.2.Clinical
14.5. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Biotechnology & Pharmaceutical Companies
14.5.2.Academic & Research Institutes
14.5.3.Contract Research Organizations (CROs)
14.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.6.1.GCC Countries
14.6.2.South Africa
14.6.3.Rest of MEA
15.Latin America In-Vitro Transcription Templates Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.1.1.DNA Templates
15.1.2.RNA Templates
15.1.3.Templates and Transcription kits
15.1.4.Other Product Types
15.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.2.1.Cancer
15.2.2.Infectious Disease
15.2.3.Lifestyle Disease
15.2.4.Genetic Disease
15.2.5.Other Diseases
15.3.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.3.1.Research
15.3.2.Diagnostics
15.3.3.Therapeutics
15.3.4.Vaccines
15.3.5.Others
15.4.  Research Stage Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.4.1.Explanatory
15.4.2.Clinical
15.5. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.5.1.Biotechnology & Pharmaceutical Companies
15.5.2.Academic & Research Institutes
15.5.3.Contract Research Organizations (CROs)
15.6.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.6.1.Brazil
15.6.2.Mexico
15.6.3.Rest of LA
16. Competition Landscape
16.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
16.2.1.Agilent Technologies Inc.
16.2.2.Bio-Rad Laboratories Inc
16.2.3.CINVEN LIMITED
16.2.4.Danaher Corporation
16.2.5.Enzo Life Sciences, Inc.
16.2.6.Enzynomics Co Ltd.
16.2.7.Eurofins Genomics LLC
16.2.8.Hoffmann-La Roche Ltd.
16.2.9.Genscript Biotech Corporation
16.2.10.Illumina Inc
16.2.11.LGC Limited
16.2.12.Life Technologies Corporation
17. Research Methodology 
18. Appendix and Abbreviations 
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc
  • CINVEN LIMITED
  • Danaher Corporation
  • Enzo Life Sciences, Inc.
  • Enzynomics Co Ltd.
  • Eurofins Genomics LLC
  • Hoffmann-La Roche Ltd.
  • Genscript Biotech Corporation
  • Illumina Inc
  • LGC Limited
  • Life Technologies Corporation
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs Inc
  • Promega Corporation
  • Qiagen N.V
  • Roche Holding AG
  • Sigma-Aldrich Corporation
  • Synbio Technologies
  • Takara Bio Company
  • Thermo Fisher Scientific Inc
  • TriLink Biotechnologies LLC

Adjacent Markets